Home » Forest Reaches More Bystolic Settlements
Forest Reaches More Bystolic Settlements
The FDA is giving generic manufacturers until Dec. 18 to complete the self-identification process without penalty — a two week extension of the original Dec. 3 deadline, CDER said. As of the Dec. 3 deadline, more than 1,700 facilities have self-identified for fiscal 2013, the FDA said. This figure is below estimates of the number of generic drug facilities.
Generic Line
Generic Line
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May